Journal:PMC:1
From Proteopedia
(Difference between revisions)

Line 11: | Line 11: | ||
====Proposition #2. Steric hinderance of some centric portion of the piperidine ring explains antagonist properties of naloxone, naltrexone and alvimopam.==== | ====Proposition #2. Steric hinderance of some centric portion of the piperidine ring explains antagonist properties of naloxone, naltrexone and alvimopam.==== | ||
- | <scene name='Journal:PMC:1/Cv1/4'>These steric effects are caused by the OH and allyl side chains which block more than a peripheral portion of the piperidine ring</scene> in Naloxone. | + | <scene name='Journal:PMC:1/Cv1/4'>These steric effects are caused by the OH and allyl side chains which block more than a peripheral portion of the piperidine ring</scene> in Naloxone. <scene name='Journal:PMC:1/Cv1/5'>Naltrexone with a bulkier side chain</scene> is more antagonistic than Naloxone. |
</StructureSection> | </StructureSection> |
Revision as of 07:49, 23 November 2011
|
- ↑ Joel S. Goldberg, Perspectives in Medicinal Chemistry 2010:4 1-10, Stereochemical Basis for a Unified Structure Activity Theory of Aromatic and Heterocyclic Rings in Selected Opioids and Opioid Peptides doi:http://dx.doi.org/10.4137/PMC.S3898
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.